Sasanejad, P, Afshar Hezarkhani, L, Arsang-Jang, S, Tsivgoulis, G, Ghoreishi, A, Kristian, B, Rahmig, J, Farhoudi, M, Sadeghi Hokmabadi, E, Borhani-Haghighi, A, Sariaslani, P, Sharifi-Razavi, A, Ghandehari, K, Khosravi, A, Smith, C, Nilanont, Y, Akbari, Y, Nguyen, TN, Bersano, A, Yassi, N, Yoshimoto, T, Lattanzi, S, Gupta, A, Zand, R, Rafie, S, Pourandokht Mousavian, S, Reza Shahsavaripour, M, Amini, S, Kamenova, SU, Kondybayeva, A, Zhanuzakov, M, Macri, EM, Nobleza, COHS, Ruland, S, Cervantes-Arslanian, AM, Desai, MJ, Ranta, A, Moghadam Ahmadi, A, Rostamihosseinkhani, M, Foroughi, R, Hooshmandi, E, Akhoundi, FH, Shuaib, A, Liebeskind, DS, Siegler, J, Romano, JG, Mayer, SA, Bavarsad Shahripour, R, Zamani, B, Woolsey, A, Fazli, Y, Mojtaba, K, Isaac, CF, Biller, J, Di Napoli, M & Azarpazhooh, MR 2021, '
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative',
Journal of Stroke and Cerebrovascular Diseases, vol. 30, no. 12, 106121.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106121